Cemiplimab for treating recurrent or metastatic cervical cancer that has progressed on or after platinum-based chemotherapy (review of TA901) [ID6610]

  • In development
  • GID-TA11850
  • Expected publication date: 

Documents

Documents created during the development process.

Declaration of interests

Committee meetings

  • Committee meeting: 1

Invitation to participate